Taken together these observations suggest that plasma-cell subpopulations of clonotypic tumor cells in LPL may exhibit immune evasion to our vaccine therapy by downregulating expression of HLA genes, rather than by activation of T-cell immune checkpoints. This evidence concerns the gene LPL and neoplasm.